Effects of ALA supplementation on PSA velocity and on the combined endpoint of prostate cancer and a PSA level above 4 ng/mL were in the direction of a raising effect, but the confidence intervals were wide and all included 1. Here, KLK3 is linked to prostate carcinoma.